Disproportion of economic impact, research achievements and research support in digestive diseases in Canada

Clinical and Investigative Medicine

Volumn 24, Issue 1, 2001, Pages 12-36

  Beck, I T ^a  

^a HOTEL DIEU HOSPITAL   (Canada)

Author keywords

Academies and institutes; Awards and prizes; Biological sciences; Colonic diseases, functional; Digestive system diseases; Dyspepsia; Fellowships and scholarships; Financing, organized; Gastrointestinal diseases; Health care economics and organizations; Research; Research support; Societies

Indexed keywords

ACHIEVEMENT; ARTICLE; CANADA; CLINICAL TRIAL; DATA ANALYSIS; DISEASE SEVERITY; ECONOMICS; GASTROINTESTINAL DISEASE; GOVERNMENT; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; MEDICAL RESEARCH; MULTICENTER STUDY; OUTPATIENT; PRIORITY JOURNAL;

CANADA; DIGESTIVE SYSTEM; FOUNDATIONS; HEALTH CARE COSTS; HUMANS; RESEARCH; RESEARCH SUPPORT;

EID: 0035098960     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (211)

1. Canadian gastroenterology: Yesterday, today and tomorrow
2. Guidelines of the previous consensus conference and recent developments
3. The economic burden of irritable bowel syndrome in Canada
4. Prevalence impact of upper gastrointestinal symptoms in the Canadian population: Findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study
5. Prevalence and impact of lower gastrointestinal (LGI) symptoms in the Canadian population: Findings from the DIGEST study
6. Evaluation of Canadian Association of Gastroenterology research fellowship program between 1986 and 1997
7. Canadian research fellowship training programs in digestive sciences: Achievements and challenges
8. Growth of the Canadian Association of Gastroenterology Controlled, effective and impressive
9. Research funding by the CAG reaches its highest level ever!
10. A Canadian physician survey of dyspepsia management
11. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction
12. Irritable bowel syndrome in the general population
13. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact
14. The psychological general well-being (PGWB) index
15. Effects of 12 weeks of ramipril treatment on the quality of life in patients with moderate congestive heart failure: Results of a placebo-controlled trial
16. Progress towards cloning the cystic fibrosis gene
17. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
18. Slow waves in circular muscle of porcine ileum: Structural and electrophysiological studies
19. The immunomodulation of enteric neuromuscular function: Implications for motility and inflammatory disorders
20. Neuromuscular mechanisms of primary peristalsis
21. Myogenic mechanism for peristalsis in the cat esophagus
22. Esophageal motility in the elderly
23. Responses of the gastroesophageal junctional zone to increases in abdominal pressure
24. First description of the "migrating motor complex" and its physiological function in the human jejunum
25. Esophagitis as the outcome of progressive failures of the defensive repertoire
26. Role of mast cell-derived mediators in acid-induced shortening of the esophagus
27. The effect of cisapride in patients with reflux esophagitis An ambulatory esophageal manometry/pH-metry study
28. Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: A cost minimization analysis
29. Delayed rectifier and Ca(2+)-dependent K(+) currents in human esophagus: Roles in regulating muscle contraction
30. GLP-2 augments the adaptive response to massive intestinal resection in rat
31. Anaphylaxis-induced alterations in intestinal motility: Role of extrinsic neural pathways
32. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease
33. Cognitive evoked potentials to anticipated oesophageal stimulus in humans: Quantitative assessment of the cognitive aspects of visceral perception
34. Cortical evoked responses following esophageal balloon distension and electrical stimulation in healthy volunteers
35. The cortical topography of human anorectal musculature
36. Slow wave and spike action potentials recorded in cell cultures from the muscularis externa of the guinea pig small intestine
37. Correlation of morphology, electrophysiology and chemistry of neurons in the myenteric plexus of the guinea-pig distal colon
38. Immediate-early gene expression in the inferior mesenteric ganglion and colonic myenteric plexus of the guinea pig
39. Neural injury, repair, and adaptation in the GI tract. IV. Pathophysiology of GI motility related to interstitial cells of Cajal
40. Interstitial cells of Cajal: Pacemaker cells?
41. Sympathetic nerve contact causes maturation of mast cells in vitro
42. Characteristics of inflammation-induced hypertrophy of rat intestinal smooth muscle cell
43. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism
44. Damage to the enteric nervous system in experimental colitis
45. Role of maxi-K+ channels in endothelin-induced vasoconstriction of mesenteric and submucosal arterioles
46. A novel in vitro model of Brunner's gland secretion in the guinea pig duodenum
47. Organization of intrinsic cholinergic neurons projecting within submucosal plexus of guinea pig ileum
48. Rat gastroduodenal motility in vivo: Interaction of GABA and VIP in control of spontaneous relaxations
49. Neurochemical characterization and distribution of enteric GABAergic neurons nerve fibres in the human colon
50. Intestinal permeability in allergic rats: Nerve involvement in antigen-induced changes
51. Motilin, a gastric motor activity stimulating polypeptide: The complete amino acid sequence
52. Discovery of motilin
53. Neural mediation of the motilin motor effect on the human antrum
54. Heterogeneity of motilin receptors in the gastrointestinal tract of the rabbit
55. Regulation of motilin release: Studies with ex vivo perfused canine jejunum
56. Canadian Helicobacter pylori Consensus Conference update: Infections in adults
57. Costeffectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada
58. Nitric oxide. V. Therapeutic potential of nitric oxide donors inhibitors
59. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage?
60. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease
61. Reduction by cytoprotective agents of ethanol-induced damage to the rat gastric mucosa: A correlated morphological and physiological study
62. Selective inhibitors of cyclooxygenase-2: Are they really effective, selective, and GI-safe?
63. The gastric transitional zones: Neglected links between gastroduodenal pathology and Helicobacter ecology
64. Topical nicotine protects rat gastric mucosa against ASA-induced damage. A role for mucosal fluid secretion in cytoprotection
65. The pathogenesis of duodenal gastric metaplasia: The role of local goblet cell transformation
66. Gastric cytoprotection is secondary to increased mucosal fluid secretion: A study of six cytoprotective agents in the rat
67. Feeding an isocaloric omega-3 fatty acid diet reduces the brush border membrane vesicle uptake of glucose in streptozotocin-diabetic rats
68. Stanniocalcin: A novel protein regulating calcium and phosphate transport across mammalian intestine
69. The small intestine in vitamin D dependent rickets
70. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat
71. Adaptive cytoprotection against ethanol-induced small intestinal mucosal injury
72. Small bowel review: Part I
73. Small bowel review Part II
74. Insulin downregulates diabetic-enhanced intestinal glucose transport rapidly in ileum, and slowly in jejunum
75. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease
76. Rapid transepithelial antigen transport in rat jejunum: Impact of sensitization and the hypersensitivity reaction
77. Small bowel injury by ethanol
78. Nippostrongylus brasiliensis infection evokes neuronal abnormalities and alterations in neurally regulated electrolyte transport in rat jejunum
79. Hapten-induced model of chronic inflammation and ulceration in the rat colon
80. Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis
81. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
82. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
83. Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion
84. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora
85. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease
86. Intestinal permeability in Crohn's disease
87. Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease
88. Operative environmental risk factors for recurrence of Crohn's disease
89. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
90. Oral budesonide as maintenance treatment for Crohn's disease: A placebocontrolled, dose-ranging study
91. Combination ciprofloxacin and metronidazole for active Crohn's disease
92. Critical assessment of body-composition measurements in malnourished subjects with Crohn's disease: The role of bioelectric impedance analysis
93. Total enteral nutrition support improves body composition of patients with active Crohn's disease
94. The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease
95. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
96. Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants
97. Functional bowel disorders and functional abdominal pain
98. Early life abuses in the past history of patients with gastrointestinal tract and pelvic floor dysfunctions
99. The classification of digestive problems into "organic" "functional" should not be abandoned: A surgical point of view
100. Anismus as a marker of sexual abuse. Consequences of abuse on anorectal motility
101. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome
102. The role of angiotensin in the intestinal vascular response to hypotension in a canine model
103. Ethanol-induced vascular permeability changes in the jejunal mucosa of the dog
104. Shear stress-induced nitric oxide antagonizes adenosine effects on intestinal metabolism
105. The HISS story overview: A novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes
106. Potentiation to vasodilators by nitric oxide synthase blockade in superior mesenteric but not hepatic artery
107. Shear-induced modulation of vasoconstriction in the hepatic arteryportal vein by nitric oxide
108. Blockade of hepatic nitric oxide synthase causes insulin resistance
109. A critical role for nitric oxide in intestinal barrier function and dysfunction
110. Endogenous but not exogenous nitric oxide decreases TNF-alpha-induced leukocyte rolling
111. Sustained gallbladder stasis promotes cholesterol gallstone formation in the ground squirrel
112. The effects of liver transplantation and cyclosporine on bile formation lipid composition: An experimental study in the rat
113. Nutrition as primary therapy in pediatric Crohn's disease: Fact or fantasy?
114. Variable expression of familial heterozygous hypobetalipoproteinemia: Transient malabsorption during infancy
115. Nutritional assessment
116. The role of pancreatic enzymes in the pathogenesis of acute pancreatitis. II. The fate of pancreatic proteolytic enzymes in the course of acute pancreatitis
117. Histopathology of acute pancreatitis
118. Inherited and congenital disorders of the exocrine pancreas
119. Exclusion of linkage of Shwachman-Diamond syndrome to chromosome regions 6q and 12q implicated by a de novo translocation
120. Postnatal development of the rat exocrine pancreas. I. Alterations in high- and low-affinity cholecystokinin receptors and enzyme secretion
121. Postnatal development of the rat exocrine pancreas. II. Effects of protein-calorie malnutrition on amylase secretion and CCK receptor binding
122. A hypothesis: SNARE-ing the mechanisms of regulated exocytosis and pathologic membrane fusions in the pancreatic acinar cell
123. The vesicle-associated membrane protein family of proteins in rat pancreatic and parotid acinar cells
124. Protein tyrosine phosphorylation in pancreatic acini differential effects of VIP, and CCK
125. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth
126. Expression and modulation of p42/p44 MAPKs and cell cycle regulatory proteins in rat pancreas regeneration
127. Localization of rat pancreatitis-associated protein during bile salt-induced pancreatitis
128. Liver disease associated with alphal-antitrypsin deficiency in childhood
129. Wilson's disease: A common liver disorder?
130. Kinetics of endothelin-1 binding in the dog liver microcirculation in vivo
131. Hepatic uptake of protein-bound ligands: Effect of an unstirred Disse space
132. Use of proliferating cell nuclear antigen as a marker of liver regeneration after partial hepatectomy in rats
133. The beneficial effects of ciprofloxacin on survival and hepatic regenerative activity in a rat model of fulminant hepatic failure
134. Asymptomatic primary biliary cirrhosis: A study of its natural history and prognosis
135. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis
136. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
137. Evolving expression of hereditary hemochromatosis
138. Screening blood donors for hereditary hemochromatosis Decision analysis model comparing genotyping to phenotyping
139. Interferon therapy prevents hepatocellular carcinoma in some patients with chronic HCV: The role of fibrosis
140. Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study
141. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease
142. Lamivudine therapy for chronic hepatitis B: A six-month randomized dose-ranging study
143. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2′,3′-dideoxy-3′-thiacytidine
144. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
145. Ascites and renal disorders in liver disease
146. The controversy over the pathophysiology of ascites formation in cirrhosis
147. Liver retransplantation
148. Patient survival after tertiary liver transplantation
149. Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation
150. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: Clinical results and lack of pigto-human transmission of the porcine endogenous retrovims
151. Xenotransplantation: A potential solution to the critical organ donor shortage
152. Lack of relationship between preoperative measures of the severity of cirrhosis and short-term survival after liver transplantation
153. Development of organ transplantation in Quebec from 1985 to January 1990
154. Role of ERCP in the diagnosis of intraductal papillary mucinous neoplasms
155. Optical coherence tomography A new light in GI endoscopy?
156. Photodynamic therapy for the treatment of tumor ingrowth in expandable esophageal stents
157. The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease
158. Health economics of gastroesophageal reflux disease
159. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital
160. Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program
161. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders
162. History of the first 30 years of the Canadian Association of Gastroenterology
163. Defining and measuring the costs of the HIV epidemic to business firms
164. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991
165. Cost-of-illness methodology. A guide to current practices and procedures
166. Costs of illness in cost-effectiveness analysis A review of the methodology
167. Cost-of-illness studies: Fact or fiction?
168. The economic value of life Linking theory to practice
169. The value of human life revisited
170. Crohn's disease and ulcerative colitis - Morbidity and mortality: The Canadian experience
171. Digestive diseases in the United States: Epidemiology and impact
172. The relation between funding by the National Institutes of Health and the burden of disease
173. Cost of digestive disease in the United States
174. Canadian Association of Gastroenterology Practice Guidelines: Evaluation of dysphagia
175. Canadian Association of Gastroenterology Practice Guidelines Management of noncardiac chest pain
176. Canadian Association of Gastroenterology Practice Guidelines Evaluation of abnormal liver enzyme tests
177. Funding medical health-related research in the public interest
178. Time to put the Canadian Institutes of Health Research on trial
179. Lobbyists seek to reslice NIH's pie